MedPath

Effects of a Western-type Diet on Colorectal Inflammation

Early Phase 1
Completed
Conditions
Colorectal Inflammation
Interventions
Dietary Supplement: Western style diet (high fat and low in calcium)
Dietary Supplement: Prudent-style diet (low fat and high in calcium)
Registration Number
NCT00866450
Lead Sponsor
Rockefeller University
Brief Summary

This study will look at the inflammatory (changes usually associated with infection/injury to the body) and bowel permeability (bowel's ability to allow contents to enter the body) effects of a Western-style diet (high fat and low in calcium) and a prudent-style diet (low fat and high in calcium) on the colon (large bowel). This study may provide information to prevent colorectal cancer in a high-risk population

Detailed Description

Hypothesis: Compared to a prudent-style diet, does a western-style diet increase colorectal inflammation thereby increasing gut permeability and causing increased endotoxins and markers of systemic inflammation.

This is a single blind crossover study. Subjects will be randomized to begin on either a WD or a PD for 30 + 3 days. Once that dietary intervention is complete, subjects will have a four (4) week wash-out period and then will be placed on the other dietary intervention for 30 + 3 days. The following study measures are performed during both the dietary intervention study periods. All the baseline tests will be repeated at the end of each dietary intervention period.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
5
Inclusion Criteria
  • Healthy male or post-menopausal ( 2 years after menopause or stopping HRT)healthy female subjects
  • Age between 50 and 72 years
  • At increased risk for colorectal cancer (this includes those have had a colorectal adenoma excised, or have a first or second degree relative with colorectal neoplasia).
Exclusion Criteria
  • Personal history of cancer other than non-melanoma skin cancer within the past 10 years
  • History of hereditary non-polyposis colon cancer
  • Intestinal malabsorption, inflammatory bowel disease
  • Prior gastrointestinal surgery other than appendectomy or surgery of the esophagus
  • Any excess bleeding or coagulation disorders
  • Subjects taking anti-coagulants, sterol-binding resins, NSAIDs other than aspirin, < 600mg per day, other study medications, or other multiple medications that might, in the view of the study physicians, alter colonic function or inflammation
  • Total cholesterol greater than 240mg/dl, triglycerides > 600mg, LDL-C > 175
  • Subjects with a history of coronary artery disease
  • HIV positive subjects
  • Subjects taking antibiotics, anti-diabetes, hormone replacement therapy, oral, transplanted or injected contraceptives (thyroid hormone therapy is permitted as long as the subject is euthyroid)
  • Currently participating in other clinical studies or completed participation in other clinical studies within the last 30 days

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Western style dietWestern style diet (high fat and low in calcium)high-fat, low-calcium diet
Prudent dietPrudent-style diet (low fat and high in calcium)low-fat, calcium-sufficient diet
Primary Outcome Measures
NameTimeMethod
Inflammation in the rectosigmoid epitheliumvisit 1, 30 days after the first dietary intervention and 30 days after the second dietary intervention
Secondary Outcome Measures
NameTimeMethod
Inflammatory cytokines in the colorectal mucosa and serumvisit 1, 30 days after the first dietary intervention and 30 days after the second dietary intervention
Circulating endotoxin levelsvisit 1, 30 days after the first dietary intervention and 30 days after the second dietary intervention
Expression profiles of pro- and anti-inflammatory genes in rectosigmoid biopsiesvisit 1, 30 days after the first dietary intervention and 30 days after the second dietary intervention
Gut permeabilityvisit 1, 30 days after the first dietary intervention and 30 days after the second dietary intervention
Luminal and adherent gut microbiotavisit 1, 30 days after the first dietary intervention and 30 days after the second dietary intervention
Fecal calprotectin levels in the stool samplesvisit 1, 30 days after the first dietary intervention and 30 days after the second dietary intervention

Trial Locations

Locations (1)

Rockefeller University

🇺🇸

New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath